Personalis, Inc. (PSNL)
6.73
+0.07
(+1.05%)
USD |
NASDAQ |
Apr 17, 16:00
6.65
-0.08
(-1.19%)
After-Hours: 06:55
Personalis SG&A Expense (Quarterly) : 14.09M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 33.08M |
| Celldex Therapeutics, Inc. | 11.94M |
| Plus Therapeutics, Inc. | 4.168M |
| Atossa Therapeutics, Inc. | 5.28M |
| Abeona Therapeutics, Inc. | 18.78M |